Stay updated on Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.

Latest updates to the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page footer revision label was updated from v3.6.3 to v3.6.4, indicating a small site release. This change does not affect study information or how users interact with the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new version entry updates the Contacts/Locations and Study Status, aligned with a revision update (v3.6.3) dated 2026-06-30.SummaryDifference0.2%

- Check29 days agoChange DetectedThe revision history now includes a new platform release tag: Revision: v3.6.2, replacing the previous v3.6.0 entry. This represents an internal software update and does not alter the study data or on-page information.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study history now shows that enrollment is closed to new participants, and the history includes a new Revision: v3.6.0 while removing the earlier Revision: v3.5.5.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page now shows Revision: v3.5.5 in the footer, replacing Revision: v3.5.4. This reflects a routine metadata update indicating a new version of the page rather than substantive changes to the study content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page history shows a new Revision: v3.5.4, replacing the previous v3.5.3. This reflects a small platform version update.SummaryDifference0.0%

Stay in the know with updates to Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.